Drug Database
UR

Uralyt-K

✓ Approved

Rottapharm Madaus · 小分子 · 小分子

什么是 Uralyt-K?

Uralyt-K 是一种小分子,由Rottapharm Madaus研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)。

药物档案

公司Rottapharm Madaus
药物类别小分子
给药途径Oral (PO)
状态Approved

治疗适应症

Uralyt-K 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Renal and urinary disordersCalculus urinary✓ Approved

相关研究文献

PubMedThe Medical journal of Australia2026-11-19

Influenza A(H3N2) Subclade K Activity in Australia in 2025: Epidemiology and Vaccine Effectiveness Results From General Practice Sentinel Surveillance.

Chilver Monique B N MBN, Sullivan Sheena G SG, Selway Caitlin A CA, Miller Jessica E JE et al.

To describe the epidemiology, clinical characteristics, vaccine effectiveness (VE), antiviral prescribing and virological properties for influenza A(H3N2) subclade K detected through Australian general practice sentinel surveillance in 2025. Retrospective, observational study using routinely collected general practice surveillance data; VE was estimated using a test-negative design. Data were collected from sentinel general practice sites participating in Australian Sentinel Practices Research Network surveillance across Australia during International Organization for Standardization weeks 1-52 of 2025. Patients presenting with influenza-like illness were systematically selected for virological sampling. Demographic and clinical characteristics of patients with laboratory-confirmed influenza; VE against general practice-attended, laboratory-confirmed influenza; antiviral prescribing; and sequence-based markers of reduced antiviral susceptibility. Among 3185 patients with influenza-like illness who were swabbed, 666 (21%) tested positive for influenza. Influenza A(H3N2) subclade K was first detected in week 34 of 2025 and circulated beyond the typical influenza season, peaking in November-December. Of 98 subclade K detections, 36 (37%) were in children aged 5-17 years. Compared with other types, subtypes or subclades of influenza, clinical presentations of subclade K cases were broadly similar, with no consistent clinical pattern distinguishing subclade K. VE against subclade K was 50% overall (95% confidence interval, 8.9-73) and 76% among persons aged 9 months to 17 years (95% confidence interval, 18-93). Among all patients with a recorded antiviral prescription, two-thirds were within the recommended 48-h symptom onset window (76/114). No subclade K viruses had mutations known to reduce susceptibility to the influenza antivirals assessed, including oseltamivir. Among patients attending Australian sentinel general practices in 2025, subclade K prolonged influenza activity into the summer months. General practice sentinel surveillance of influenza can provide timely information on emerging variants and changes in the timing of influenza circulation, raising clinical awareness outside the usual season, informing vaccination strategies and prompting assessment for antiviral treatment.

PMID 43053545
阅读全文 →
PubMedOmics : a journal of integrative biology2026-11-19

Differential Expression and Therapeutic Targeting of K+ Channels in Neurological Disorders: An Integrative Approach.

Maqsood Laiba L, Azeem Farrukh F, Zubair Muhammad M, Azmat Saira S et al.

Potassium (K+) channels regulate cellular homeostasis and electrical signaling, particularly in the nervous system, and their dysfunction is linked to neurological disorders such as epilepsy, Alzheimer's disease (AD), and Parkinson's disease (PD). In this study, Gene Expression Omnibus (GEO) datasets (GSE252132, GSE190451, and GSE160299) were analyzed using GEO2R to identify differentially expressed K+ channel genes. A total of 2741, 3681, and 861 differentially expressed genes were identified in AD, epilepsy, and PD, respectively, including the common K+ channel genes KCNJ5, KCNJ6, and KCNJ12. Functional enrichment using Enrichr highlighted potassium ion transport, potassium channel complexes, voltage-gated potassium channel activity, and gonadotropin-releasing hormone secretion. STRING and Cytoscape-based protein-protein interaction and Molecular Complex Detection analyses identified 13 hub genes, including KCNJ6, KCNJ5, and KCNJ12. miRNet analysis identified 12 miRNAs, 1 transcription factor, and 7 target genes, with hsa-miR-138-5p predicted to regulate KCNJ6. Virtual screening of 2315 Food and Drug Administration-approved drugs and 2390 Traditional Chinese Medicine compounds identified Sorafenib, Hinokiflavone, Posaconazole, and 1,3,6-Tri-O-galloyl-beta-D-glucose as promising KCNJ6-binding candidates. These findings highlight K+ channels, particularly KCNJ6, as biomarkers and therapeutic targets in neurological disorders.

PMID 43052235
阅读全文 →
PubMedBMC public health2026-11-19

Association of blood-pressure time-in-therapeutic range with morbidity and mortality in hypertensive patients: a retrospective cohort study in the community setting.

Alonso-Safont Tamara T, Polentinos-Castro Elena E, Del-Cura-González Isabel I, Bilbao-González Amaia A et al.

Hypertension is one of the leading modifiable risk factors for cardiovascular disease. This study assessed the association between good blood pressure control (GBPC), measured by time in therapeutic range (TTR) during the first year after hypertension diagnosis, and kidney or cardiovascular (K/CV) events and mortality in a large real-world cohort. This population-based retrospective cohort included adults newly diagnosed with hypertension in primary care in Madrid, Spain, between 2007 and 2008, with no previous K/CV disease. Participants were identified from electronic medical records; outcomes were recorded until December 31, 2018, death, or deregistration. TTR during the first year was calculated using the indirect (iTTR; proportion of follow-up time within the BP target range) and direct (dTTR; proportion of BP measurements within the BP target range) methods. GBPC was defined as the highest TTR quartile (≥ 81% for iTTR and ≥ 67% for dTTR) or the last office BP measurement < 140/90 mmHg. Associations with mortality and K/CV events were evaluated using Cox regression models. A total of 38,002 patients were included (median age, 59 years [IQR, 49-69]; 53.9% women), with a median follow-up of 130.6 months (IQR, 123.1-137.3). During follow-up, 3,947 patients died (899 from K/CV causes), yielding an all-cause mortality rate of 8.24 per 10,000 person-months. A total of 11,727 K/CV events occurred, including 401 deaths. After adjustment for covariates, GBPC was associated with a 28% lower risk of all-cause mortality (95% CI, 5-45%) in patients diagnosed before 55 years (iTTR) and a 10% lower risk (95% CI, 0-20%) in those aged 55-74 years (iTTR and dTTR). GBPC was also associated with lower K/CV risk in patients aged < 55 years (11% [95% CI, 1-20%] for iTTR and 17% [95% CI, 8-25%] for dTTR) and 55-74 years (11% [95% CI, 6-16%] for iTTR and 10% [95% CI, 4-14%] for dTTR). No significant associations were observed at ≥ 75 years. Good blood pressure control during the first year after diagnosis, defined using TTR and a BP target of < 140/90 mmHg, was associated with lower risks of mortality and K/CV events among patients diagnosed before age 75 years.

PMID 43052892
阅读全文 →
PubMedJournal of neurochemistry2026-11-19

Twenty Years of the Concept of the Privileged Extracellular Region: From Early Computations to Modern Anatomical Evidence.

Chvátal Alexandr A

The brain extracellular space (ECS) is a heterogeneous and plastic compartment. The concept of the privileged extracellular region (PER) was introduced in 2004 as a computationally derived, spatially restricted microdomain of the ECS immediately surrounding glial cells, within which potassium (K+) accumulates preferentially and independently from the broader extracellular milieu. Using mathematical modeling of membrane currents in astrocytes and oligodendrocytes, the seminal paper demonstrated that the volume of the ECS accessible for K+ accumulation during depolarization was 10-100-fold smaller around oligodendrocytes than around astrocytes, establishing the first quantitative evidence for spatial heterogeneity of the periglial ECS. Over the following two decades, converging lines of structural, functional, and clinical evidence have dramatically expanded this concept. Perisynaptic astrocytic regions and extracellular geometry have now been visualized at nanoscale resolution using STED, dSTORM, and super-resolution shadow imaging (SUSHI), revealing a spongiform architecture with fine leaflets and reflexive loops that delineate functionally distinct microdomains at the synaptic interface. EAAT2/GLT-1 glutamate transporters and Kir4.1 K+ channels concentrated within these processes provide the molecular infrastructure for localized neurotransmitter clearance and K+ siphoning. Disruption of PER geometry-through reactive gliosis, astrocytic atrophy during aging, or leaflet retraction-contributes to the pathophysiology of epilepsy, Alzheimer's disease, ischemia, and cognitive decline. The present review traces the intellectual lineage of the PER concept, integrates two decades of anatomical and functional evidence, and highlights the therapeutic implications of understanding periglial microdomains as active regulators of brain homeostasis.

PMID 43053328
阅读全文 →
PubMedBMC plant biology2026-11-19

Integrated physiological, transcriptomic and metabolomic analyses characterize treatment-associated autumn shoot self-pruning and maturation in Wogan mandarin.

Li Guoguo G, Chen Qiuyou Q, Bei Xuejun X, Luo Yin Y et al.

Autumn shoot maturation is important for citrus canopy management and subsequent reproductive development. We compared five foliar treatments but interpret their effects as treatment-specific because the salts were not equimolar and KH₂PO₄ supplied both K and P. Water (CK), 0.3% (w/v) KNO₃, 0.3% KH₂PO₄, 0.3% K₂SO₄ and a seaweed-polysaccharide product were applied twice to 15 three-year-old Wogan mandarin trees (three trees per treatment). Under an exploratory equal-weight framework, KH₂PO₄ had the highest integrated score (0.858) and remained first in all 11 leave-one-indicator-out analyses. Longitudinal mixed models detected treatment-by-linear-time interactions for shoot length, shoot diameter, internode length, leaf number, leaf width and leaf thickness, but not for self-pruning rate or SPAD. RNA-seq and untargeted LC-MS profiling of CK and KH₂PO₄ leaves and stems showed tissue- and stage-dependent responses. The broad VIP > 1 and P < 0.05 metabolite set was largest at 3 d (554 leaf and 357 stem features), whereas only 31 leaf and one stem feature at 3 d met VIP > 1 and BH q < 0.05; the remaining six comparisons had none. Co-expression, putative PPI and pathway analyses prioritized lignin-, hormone- and redox-related candidates. qRT-PCR of nine genes detected 19 FDR-significant tissue-time responses and supported several key RNA-seq expression patterns. Foliar KH₂PO₄ was associated with high leaf K, low Na, carbon-osmotic adjustment, redox stabilization and lignin-related transcription. These data identify treatment-associated candidate pathways and genes rather than a K-specific, P-specific or causal mechanism.

PMID 43052743
阅读全文 →
PubMedBMC infectious diseases2026-11-19

Resistance prevalence and temporal trends of ESKAPE pathogens from clinical samples: a 5-year retrospective study at KCMC Tertiary Hospital, Tanzania.

Mnzava Dhahiri D, Gamuya Ezekiel B EB, Hamza Iddi Maliki M, Issangya Emmanuel T ET et al.

Antimicrobial resistance due to ESKAPE pathogens (E. faecium, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, Enterobacter spp.) poses a critical global public health threat, especially in Sub-Saharan Africa. The present study aimed to investigate the epidemiological resistance prevalence and temporal trends (2019-2023) of ESKAPE pathogens and their antibiotic resistance patterns at KCMC Hospital in Northern Tanzania, providing data for the national AMR action plan. This 5-year retrospective study analysed 57,089 bacterial isolates recovered from 84,513 clinical samples collected at KCMC Hospital between 2019 and 2023. Of these bacterial isolates, 33,218 (58.2%) were identified as ESKAPE pathogens. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disk diffusion method and interpreted according to CLSI guidelines. Resistance patterns were summarised using organism- and antibiotic-specific denominators, with 95% confidence intervals calculated for key prevalence estimates. Temporal variation in resistance was assessed using appropriate categorical and trend analyses, with statistical significance defined as p < 0.05. Among all pathogens, 33,218 (58.2%) were ESKAPE pathogens. A high proportion of 14,712 (44.3%) isolates exhibited resistance across drug classes. The most prevalent pathogens were S. aureus (35.3%), K. pneumoniae (24.1%), and P. aeruginosa (20.0%). Temporal analysis showed a shift, with S. aureus prevalence decreasing (52% in 2019 to 25% in 2023) and P. aeruginosa increasing (14% to 27%). Isolates were primarily from blood (37.8%), pus (28.7%), and urine (23.8%). Critically, resistance to third-generation cephalosporins rose significantly in K. pneumoniae (20.2% to 40.1%) and A. baumannii (22.0% to 33.6%). ESKAPE pathogens, driven by increasing Gram-negative strains, represent a high burden of resistance at KCMC. The rising resistance to key antibiotics necessitates the urgent implementation of targeted antimicrobial stewardship and enhanced infection control measures in this tertiary care setting. Not applicable.

PMID 43052815
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多Uralyt-K